Novolin 30R Injection FlexPen, manufactured by Novo Nordisk Pharma, contains insulin human (recombinant). This premixed insulin is a combination of 70% intermediate-acting and 30% short-acting insulin, used to control high blood sugar in people with diabetes. It has a YJ code of 2492413G5054 and a standard of 300 units per kit.
Novolin 30R Injection FlexPen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →